Clinical Trial Update: Empagliflozin Versus Vildagliptin in CAD Patients With T2DM [NA]

View source ↗

Summary

This clinical trial update reports the completion of a head-to-head comparison of empagliflozin versus vildagliptin in patients with coronary artery disease and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Damanhour University | Conditions: Coronary Artery Disease, Type 2 Diabetes | NA | Status: COMPLETED